![Jay Kleiman](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jay Kleiman
Plus aucun poste en cours
Health Technology
Profil
Jay Kleiman is Vice President of Northfield Laboratories, Inc. He was Chief Medical Officer and Head of Cardiovascular Development for Vasogen, Inc.
Anciens postes connus de Jay Kleiman
| Sociétés | Poste | Fin |
|---|---|---|
Northfield Laboratories, Inc.
 Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Corporate Officer/Principal | 10/11/2009 |
Vasogen, Inc.
 Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Directeur Technique/Scientifique/R&D | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 2 |
|---|---|
Northfield Laboratories, Inc.
Northfield Laboratories, Inc. BiotechnologyHealth Technology Develops oxygen-carrying red blood cell substitutes to treat critical blood loss | Health Technology |
Vasogen, Inc.
Vasogen, Inc. Pharmaceuticals: MajorHealth Technology Manufactures drugs to treat cardiovascular and neurodegenerative disorders | Health Technology |
